- Effects of GLP-1 (glucagon-like peptide-1) on liver2013 | Third Faculty of Medicine
- Analogues of glucagon-like peptide in clinical practice 20102011 | Second Faculty of Medicine
- Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-12011 | Second Faculty of Medicine, Third Faculty of Medicine
- Incretin mimetics in the treatment of type 2 diabetes2014 | Faculty of Medicine in Hradec Králové
- Current pharmacotherapy options in pediatric obesity2023 | Second Faculty of Medicine, Third Faculty of Medicine
- Teduglutide therapy in patients with short bowel syndrome2021 | Second Faculty of Medicine
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Role of incretins in energy metabolism and weight changes after smoking cessation2016 | First Faculty of Medicine
- No Change in Serum Incretins Levels but Rise of Leptin Levels After Smoking Cessation: a Pilot Study2016 | First Faculty of Medicine
- Effects of GLP-1 Infusion Upon Whole-body Glucose Uptake and Skeletal Muscle Perfusion During Fed-state in Older Men2023 | Publication without faculty affiliation
- Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids2017 | Third Faculty of Medicine
- Semaglutide and atherosclerosis: the present knowledge and perspectives2023 | First Faculty of Medicine
- Victoza changes diabetes and lives of patients 5 years already2016 | Faculty of Medicine in Hradec Králové
- Exenatide2008 | Second Faculty of Medicine
- Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group2016 | First Faculty of Medicine
- Dulaglutide and Cardiovascular and Heart Failure Outcomes in Patients With and Without Heart Failure: A Post-hoc Analysis from the REWIND Randomized Trial2022 | Publication without faculty affiliation
- Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure2017 | Central Library of Charles University
- Oral antidiabetic drugs in treatment of type 1 diabetes mellitus2016 | Second Faculty of Medicine, Third Faculty of Medicine
- Farmakoterapie arteriální hypertenze u pacientů s diabetes mellitus 2. typu2022 | First Faculty of Medicine
- Léčba obezity u pacientů s diabetem: přehled současných možností a výhledy do budoucna2022 | First Faculty of Medicine
- Semaglutide2019 | First Faculty of Medicine
- CAPTURE: CVD prevalence in adults with type 2 diabetes in the Czech Republic2022 | First Faculty of Medicine
- Antidiabetic drugs and cardiovascular risk - before and now2012 | First Faculty of Medicine
- Lixisenatide - a novel prandial GLP-1 receptor agonist2013 | Second Faculty of Medicine
- Comparison of clinical efficacy of DPP-4 inhibitors sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- Therapy based on the incretin effect2009 | Second Faculty of Medicine
- Liraglutide2009 | Second Faculty of Medicine
- TCF7L2 rs7903146-macronutrient interaction in obese individuals' responses to a 10-wk randomized hypoenergetic diet2010 | Third Faculty of Medicine
- Incretin hormones and the role of incretin mimetics in the treatment of type 2 diabetes mellitus2006 | Second Faculty of Medicine
- Incretins in the treatment of type 2 diabetes2008 | Second Faculty of Medicine